Oncolytics Biotech (ONCY) Receivables - Other (2016 - 2026)
Oncolytics Biotech (ONCY) posted Receivables - Other of $1.21 million for Q2 2026, compared with $51,963 a year earlier.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Receivables - Other (2016 - 2026) Analysis & Trends
At the end of FY2025, Oncolytics Biotech's Receivables - Other came in at $573,000.
- Annual Receivables - Other shows a five-year compound annual growth rate of 53.6% (FY2020 to FY2025).
- In prior years, Oncolytics Biotech's Receivables - Other was $47,000 in FY2024 (+322.8%), $11,117 in FY2023 (-97.2%), $400,736 in FY2022 (-42.0%) and $691,029 in FY2021 (+932.5%).
- The Q2 2026 figure stands as the highest quarterly Receivables - Other since Q4 2019.
- The strongest year-over-year quarter for Receivables - Other in the past five years was Q4 2021, with growth of 899.0%; the weakest was Q4 2023, with a decline of 97.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Oncolytics Biotech | 60.94 Mn | 32.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.21 Mn |
| Dec 31, 2025 | 573,000.00 |
| Sep 30, 2025 | 38,803.69 |
| Jun 30, 2025 | 52,626.19 |
| Mar 31, 2025 | 62,198.18 |
| Dec 31, 2024 | 3.48 Mn |
| Sep 30, 2024 | -65,882.98 |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 75,354.61 |
| Dec 31, 2023 | 3.78 Mn |
| Sep 30, 2023 | 466,977.99 |
| Jun 30, 2023 | 421,886.77 |
| Mar 31, 2023 | 539,864.97 |
| Dec 31, 2022 | 360,094.42 |
| Sep 30, 2022 | 363,344.17 |
| Jun 30, 2022 | 276,020.91 |
| Mar 31, 2022 | 81,889.56 |
| Dec 31, 2021 | 613,602.80 |
| Sep 30, 2021 | 197,054.21 |
| Jun 30, 2021 | 109,595.69 |
API Access
Oncolytics Biotech Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();